Emblation has received the ‘Innovative Collaboration’ award at the 17th annual Life Sciences awards. Co founders, Gary Beale and Eamon McErlean, were presented with this award at the 2017 annual awards dinner on Thursday 2nd February at the National Museum of Scotland.
Emblation received the Innovative Collaboration award in recognition of the impact their patented technology has had within the field of Oncology. In collaboration with one of the world’s largest medical device organisations, Emblation designed and developed next generation microwave ablation systems, enabling thousands of patients every month to benefit from cancer treatment where previously, options were severely limited.
Gary Beale, Emblation CEO, commented: “It was a great honour to even be nominated amongst such notable companies, but to win this prestigious award both validates our approach and recognises the dedication of our employees and trusted advisors.
Working with a global player like Covidien has allowed us to bring a pioneering solution to a global patient population. I’m immensely proud of my team – the innovation, commitment and perseverance that was necessary to bring this product to market typifies the strength and skills of the growing Life Sciences Industry in Scotland.”
The Scottish Life Science awards highlight the success and achievements of organisations within the Scottish Life Sciences sector – a globally recognised industry which contributes more than £4.2 billion a year to the Scottish economy.